+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Quantitative pathological variables as prognostic factors for overall survival in Danish patients with FIGO stage III ovarian cancer



Quantitative pathological variables as prognostic factors for overall survival in Danish patients with FIGO stage III ovarian cancer



International Journal of Gynecological Cancer 6(3): 168-174




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 062559679

Download citation: RISBibTeXText

DOI: 10.1046/j.1525-1438.1996.06030168.x


Related references

Neoadjuvant chemotherapy for FIGO stage III or IV ovarian cancer: Survival benefit and prognostic factors. International Journal of Gynecological Cancer 13(5): 587-592, 2003

Prognostic factors and prognostic groups for overall survival of cervical cancer patients FIGO stage IB1. Akusherstvo i Ginekologiia 52(Suppl. 1): 3-8, 2014

Treatment of ovarian cancer at FIGO stage III and IV--prognostic factors for patients receiving neoadjuvant chemotherapy. Nihon Sanka Fujinka Gakkai Zasshi 45(7): 665-672, 1993

The prognostic significance of residual diseases, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer. Gynecologic Oncology 56(2): 175-180, 1995

Prognostic factors for patients treated for a recurrent FIGO stage III ovarian cancer: a retrospective study of 108 cases. European Journal of Surgical Oncology 37(11): 971-977, 2011

Prognostic factors predicting survival in patients with FIGO stage IB cervical cancer treated surgically. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 94(2): 143-144, 2006

Prognostic Factors in Patients Undergoing Primary Cytoreductive Surgery for FIGO Stage IIIC Ovarian, Tubal or Peritoneal Cancer. Journal of Obstetrics and Gynaecology Canada 40(4): 447-453, 2017

The significance of differences in prognostic value of quantitative pathologic features in FIGO stage III and IV serous adenocarcinoma of the ovary between a group of Danish patients and other groups. International Journal of Gynecological Cancer 5(5): 355-360, 1995

Value of quantitative pathological variables as prognostic factors in advanced ovarian carcinoma. Journal of Clinical Pathology 49(2): 142-148, 1996

-CA-125 antigen as a prognostic factor for survival in patients with epithelial ovarian carcinoma of FIGO stage I--preliminary results-. Geburtshilfe und Frauenheilkunde 56(2): 79-82, 1996

In Dutch and Danish patients with FIGO III ovarian carcinoma, geographic survival differences are associated with differences in quantitative pathologic features. International Journal of Gynecological Cancer 6(2): 108-114, 1996

Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment. Gynecologic Oncology 68(1): 47-53, 1998

Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV. Gynecologic Oncology 140(2): 215-220, 2016

Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network. Annals of Surgical Oncology 23(4): 1279-1286, 2016

The effect of adjuvant chemotherapy on survival in patients with FIGO stage I high-grade serous ovarian cancer. Gynecologic Oncology 2019, 2019